共 50 条
- [1] Studies on the efficacy of pyrotinib in the treatment of HER-2 positive advanced solid tumors.JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)Fan, Shaoshuang论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R ChinaJiang, Da论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R ChinaLv, Yalei论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R ChinaCui, Yanzhi论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R ChinaKong, Yan论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R ChinaDong, Qian论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R ChinaHuang, Fang论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R ChinaZhang, Xue论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R ChinaWang, Long论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R ChinaZhou, Xinliang论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R ChinaJin, Hui论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R ChinaLi, Ying论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R ChinaHou, Ran论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
- [2] Studies on the Safety and Efficacy of Pyrotinib in the Treatment of HER2-Positive Advanced Solid Tumors Excluding Breast CancerCANCER MANAGEMENT AND RESEARCH, 2020, 12 : 13479 - 13487Yin, Yuzhen论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Jiangsu Shengze Hosp, Dept Tumor Ctr, Suzhou, Jiangsu, Peoples R China Nanjing Med Univ, Affiliated Jiangsu Shengze Hosp, Dept Tumor Ctr, Suzhou, Jiangsu, Peoples R ChinaYang, Hui论文数: 0 引用数: 0 h-index: 0机构: Suzhou Municipal Hosp, Dept Oncol, Suzhou, Jiangsu, Peoples R China Nanjing Med Univ, Affiliated Jiangsu Shengze Hosp, Dept Tumor Ctr, Suzhou, Jiangsu, Peoples R ChinaLiu, Zhuo论文数: 0 引用数: 0 h-index: 0机构: Zhangjiagang First Peoples Hosp, Dept Oncol, Zhangjiagang, Jiangsu, Peoples R China Nanjing Med Univ, Affiliated Jiangsu Shengze Hosp, Dept Tumor Ctr, Suzhou, Jiangsu, Peoples R ChinaTan, Jie论文数: 0 引用数: 0 h-index: 0机构: Suzhou Municipal Hosp, Dept Oncol, Suzhou, Jiangsu, Peoples R China Nanjing Med Univ, Affiliated Jiangsu Shengze Hosp, Dept Tumor Ctr, Suzhou, Jiangsu, Peoples R ChinaZhu, Chunrong论文数: 0 引用数: 0 h-index: 0机构: Soochow Univ, Affiliated Hosp 1, Dept Oncol, Suzhou, Jiangsu, Peoples R China Nanjing Med Univ, Affiliated Jiangsu Shengze Hosp, Dept Tumor Ctr, Suzhou, Jiangsu, Peoples R ChinaChen, Minbin论文数: 0 引用数: 0 h-index: 0机构: First Peoples Hosp Kunshan, Dept Oncol, Kunshan, Jiangsu, Peoples R China Nanjing Med Univ, Affiliated Jiangsu Shengze Hosp, Dept Tumor Ctr, Suzhou, Jiangsu, Peoples R ChinaZhou, Rengui论文数: 0 引用数: 0 h-index: 0机构: Chinese Peoples Liberat Army, Joint Logist Support Force, Hosp 904, Dept Oncol, Wuxi, Jiangsu, Peoples R China Nanjing Med Univ, Affiliated Jiangsu Shengze Hosp, Dept Tumor Ctr, Suzhou, Jiangsu, Peoples R ChinaWane, Lei论文数: 0 引用数: 0 h-index: 0机构: First Peoples Hosp Changzhou, Dept Breast Surg, 185 Juqian St, Changzhou, Jiangsu, Peoples R China Nanjing Med Univ, Affiliated Jiangsu Shengze Hosp, Dept Tumor Ctr, Suzhou, Jiangsu, Peoples R ChinaQian, Jun论文数: 0 引用数: 0 h-index: 0机构: Suzhou Municipal Hosp, Dept Oncol, Suzhou, Jiangsu, Peoples R China Nanjing Univ Chinese Med, Affiliated Hosp, Jiangsu Prov Hosp Chinese Med, Dept Oncol, 155 Hanzhong Rd, Nanjing, Jiangsu, Peoples R China Nanjing Med Univ, Affiliated Jiangsu Shengze Hosp, Dept Tumor Ctr, Suzhou, Jiangsu, Peoples R China
- [3] Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid TumorsJOURNAL OF ONCOLOGY, 2022, 2022Wang, Jianzheng论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R China Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R ChinaZhang, Baiwen论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Oncol, Shanghai 200127, Peoples R China Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R ChinaCheng, Xiaojiao论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Oncol, Shanghai 200127, Peoples R China Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R ChinaLi, Qingli论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Oncol, Shanghai 200127, Peoples R China Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R ChinaLv, Huifang论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R China Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R ChinaNie, Caiyun论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R China Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R ChinaChen, Beibei论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R China Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R ChinaXu, Weifeng论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R China Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R ChinaZhao, Jing论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R China Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R ChinaHe, Yunduan论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R China Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R ChinaTu, Shuiping论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Oncol, Shanghai 200127, Peoples R China Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R ChinaChen, Xiaobing论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R China Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R China
- [4] Efficacy and safety analysis of pyrotinib in lapatinib resistant HER2-positive metastatic breast cancer: A retrospective studyANNALS OF ONCOLOGY, 2020, 31 : S1262 - S1262Hua, Y.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R ChinaYang, F.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R ChinaYang, Y.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R ChinaBao, S.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R ChinaSun, C.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R ChinaYan, X.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R ChinaZeng, T.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R ChinaJiang, M.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R ChinaHuang, X.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R ChinaWu, H.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R ChinaLi, J.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R ChinaLi, W.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R ChinaYin, Y.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Oncol, Nanjing, Peoples R China
- [5] A Retrospective Real-World Study of Pyrotinib in HER-2 Positive Advanced Breast CancerCANCER MANAGEMENT AND RESEARCH, 2025, 17 : 441 - 460Yang, Zhi论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Dept Breast Surg, Wenzhou 325000, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Dept Breast Surg, Wenzhou 325000, Zhejiang, Peoples R ChinaFu, Wei-Da论文数: 0 引用数: 0 h-index: 0机构: Ningbo Univ, Affiliated Hosp 1, Dept Thyroid & Breast Surg, Ningbo 315000, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Dept Breast Surg, Wenzhou 325000, Zhejiang, Peoples R ChinaGu, Hua-Yan论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Dept Breast Surg, Wenzhou 325000, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Dept Breast Surg, Wenzhou 325000, Zhejiang, Peoples R ChinaDing, Jia-Ling论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Dept Breast Surg, Wenzhou 325000, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Dept Breast Surg, Wenzhou 325000, Zhejiang, Peoples R ChinaGuo, Gui-Long论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Dept Breast Surg, Wenzhou 325000, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Dept Breast Surg, Wenzhou 325000, Zhejiang, Peoples R China
- [6] A pilot study of safety and efficacy of pandimex with or without paclitaxel in the treatment of advanced solid tumors.JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 238S - 238SOuyang, X论文数: 0 引用数: 0 h-index: 0机构: Fuzhou Gen Hosp, Fuzhou, Peoples R ChinaYu, Z论文数: 0 引用数: 0 h-index: 0机构: Fuzhou Gen Hosp, Fuzhou, Peoples R ChinaChen, Z论文数: 0 引用数: 0 h-index: 0机构: Fuzhou Gen Hosp, Fuzhou, Peoples R ChinaXie, F论文数: 0 引用数: 0 h-index: 0机构: Fuzhou Gen Hosp, Fuzhou, Peoples R ChinaFang, W论文数: 0 引用数: 0 h-index: 0机构: Fuzhou Gen Hosp, Fuzhou, Peoples R ChinaPeng, Y论文数: 0 引用数: 0 h-index: 0机构: Fuzhou Gen Hosp, Fuzhou, Peoples R ChinaChen, X论文数: 0 引用数: 0 h-index: 0机构: Fuzhou Gen Hosp, Fuzhou, Peoples R ChinaChen, W论文数: 0 引用数: 0 h-index: 0机构: Fuzhou Gen Hosp, Fuzhou, Peoples R ChinaWang, W论文数: 0 引用数: 0 h-index: 0机构: Fuzhou Gen Hosp, Fuzhou, Peoples R ChinaQi, P论文数: 0 引用数: 0 h-index: 0机构: Fuzhou Gen Hosp, Fuzhou, Peoples R ChinaJia, W论文数: 0 引用数: 0 h-index: 0机构: Fuzhou Gen Hosp, Fuzhou, Peoples R China
- [7] Efficacy and Safety of Radiotherapy Combined with Pyrotinib in the Treatment of HER2-Positive Breast Cancer with Brain MetastasesBREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 841 - 853Huang, Jie论文数: 0 引用数: 0 h-index: 0机构: Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R China Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R ChinaZhu, Wenqiang论文数: 0 引用数: 0 h-index: 0机构: Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R China Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R ChinaDuan, Qiangzhi论文数: 0 引用数: 0 h-index: 0机构: Bengbu Med Coll, Affiliated Hosp 2, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R China Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R ChinaZhu, Chaomang论文数: 0 引用数: 0 h-index: 0机构: Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R China Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R ChinaShi, Xueling论文数: 0 引用数: 0 h-index: 0机构: Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R China Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R ChinaZhao, Hongyu论文数: 0 引用数: 0 h-index: 0机构: Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R China Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R ChinaCai, Peng论文数: 0 引用数: 0 h-index: 0机构: Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R China Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R ChinaLi, Duojie论文数: 0 引用数: 0 h-index: 0机构: Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R China Bengbu Med Coll, Affiliated Hosp 1, Dept Radiotherapy, Bengbu 233000, Anhui, Peoples R China
- [8] Efficacy and safety of pyrotinib in combination with albumin-bound paclitaxel for the treatment of HER2-positive advanced breast cancer: A real-world studyONCOLOGY LETTERS, 2023, 26 (01)Yang, Lixian论文数: 0 引用数: 0 h-index: 0机构: Xingtai Peoples Hosp, Dept Breast Surg, Xingtai 054000, Hebei, Peoples R China Xingtai Peoples Hosp, Dept Breast Surg, 818 Xiangdu Rd, Xingtai 054000, Hebei, Peoples R China Xingtai Peoples Hosp, Dept Breast Surg, Xingtai 054000, Hebei, Peoples R ChinaZheng, Lei论文数: 0 引用数: 0 h-index: 0机构: Xingtai Peoples Hosp, Dept Breast Surg, Xingtai 054000, Hebei, Peoples R China Xingtai Peoples Hosp, Dept Breast Surg, Xingtai 054000, Hebei, Peoples R ChinaKong, Fanting论文数: 0 引用数: 0 h-index: 0机构: Xingtai Peoples Hosp, Dept Breast Surg, Xingtai 054000, Hebei, Peoples R China Xingtai Peoples Hosp, Dept Breast Surg, Xingtai 054000, Hebei, Peoples R ChinaTian, Xinli论文数: 0 引用数: 0 h-index: 0机构: Xingtai Med Coll, Med Res Ctr, Xingtai 054000, Hebei, Peoples R China Xingtai Peoples Hosp, Dept Breast Surg, Xingtai 054000, Hebei, Peoples R ChinaZhang, Shiyu论文数: 0 引用数: 0 h-index: 0机构: Xingtai Peoples Hosp, Dept Breast Surg, Xingtai 054000, Hebei, Peoples R China Xingtai Peoples Hosp, Dept Breast Surg, Xingtai 054000, Hebei, Peoples R ChinaPu, Pengpeng论文数: 0 引用数: 0 h-index: 0机构: Xingtai Peoples Hosp, Dept Breast Surg, Xingtai 054000, Hebei, Peoples R China Xingtai Peoples Hosp, Dept Breast Surg, Xingtai 054000, Hebei, Peoples R China
- [9] Efficacy, safety and translational study of pyrotinib combined with albuminbound paclitaxel as firstline treatment of HER-2 positive metastatic breast cancerCANCER RESEARCH, 2024, 84 (09)Li, Huihui论文数: 0 引用数: 0 h-index: 0Man, Xiaochu论文数: 0 引用数: 0 h-index: 0Yin, Sha论文数: 0 引用数: 0 h-index: 0Zhou, Dongdong论文数: 0 引用数: 0 h-index: 0Zhang, Baoxuan论文数: 0 引用数: 0 h-index: 0Fang, Shu论文数: 0 引用数: 0 h-index: 0Zheng, Fangchao论文数: 0 引用数: 0 h-index: 0Li, Chao论文数: 0 引用数: 0 h-index: 0Wang, Xinzhao论文数: 0 引用数: 0 h-index: 0Huang, Wei论文数: 0 引用数: 0 h-index: 0Wang, Linlin论文数: 0 引用数: 0 h-index: 0He, Qingqing论文数: 0 引用数: 0 h-index: 0Fu, Hui论文数: 0 引用数: 0 h-index: 0Zhang, Yan论文数: 0 引用数: 0 h-index: 0Liu, Changrui论文数: 0 引用数: 0 h-index: 0Dong, Lin论文数: 0 引用数: 0 h-index: 0Zhao, Xianguang论文数: 0 引用数: 0 h-index: 0Xu, Liang论文数: 0 引用数: 0 h-index: 0Sun, Xiao论文数: 0 引用数: 0 h-index: 0Fan, Bingjie论文数: 0 引用数: 0 h-index: 0Song, Lihua论文数: 0 引用数: 0 h-index: 0Zhou, Zhengbo论文数: 0 引用数: 0 h-index: 0Tan, Qiaorui论文数: 0 引用数: 0 h-index: 0
- [10] TREATMENT SEQUENCING AND OVERALL SURVIVAL OF HER2POSITIVE ADVANCED BREAST CANCER IN A PERUVIAN INSTITUTIONBREAST, 2023, 71 : S50 - S51Valencia, Guillermo论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Enfermedades Neoplas, Lima, Peru Inst Nacl Enfermedades Neoplas, Lima, PeruRioja, Patricia论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Enfermedades Neoplas, Lima, Peru Inst Nacl Enfermedades Neoplas, Lima, PeruPeralta, Olenka论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Enfermedades Neoplas, Lima, Peru Inst Nacl Enfermedades Neoplas, Lima, PeruChirito, Miguel论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Enfermedades Neoplas, Lima, Peru Inst Nacl Enfermedades Neoplas, Lima, PeruMorante, Zaida论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Enfermedades Neoplas, Lima, Peru Inst Nacl Enfermedades Neoplas, Lima, PeruFuentes, Hugo论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Enfermedades Neoplas, Lima, Peru Inst Nacl Enfermedades Neoplas, Lima, PeruVidaurre, Tatiana论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Enfermedades Neoplas, Lima, Peru Inst Nacl Enfermedades Neoplas, Lima, PeruNeciosup, Silvia论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Enfermedades Neoplas, Lima, Peru Inst Nacl Enfermedades Neoplas, Lima, PeruCalderon, Monica论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Enfermedades Neoplas, Lima, Peru Inst Nacl Enfermedades Neoplas, Lima, PeruGomez, Henry L.论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Enfermedades Neoplas, Lima, Peru Inst Nacl Enfermedades Neoplas, Lima, Peru